Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Arthur Hayes: Bitcoin may replicate the trend of March last year

Arthur Hayes: Bitcoin may replicate the trend of March last year

2024/02/01 02:12

BitMEX co-founder Arthur Hayes stated on his social media platform that the New York Community Bank may face unexpected losses due to issues with loan loss reserves, which could trigger a sell-off of its stocks. Therefore, the Federal Reserve might soon start printing money. He predicts that Bitcoin will be slightly sluggish, but if the New York Community Bank is sold off, regulators will immediately intervene for rescue and at that time Bitcoin will replicate its trend from March last year. Note: Bitcoin increased by 22.96% in March 2023.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Yen appreciation and global bond slump lead Japan GPIF to first loss in six quarters, with almost no asset allocation adjustment

According to the latest quarterly report from Japan’s Government Pension Investment Fund (GPIF), its asset allocation remained almost unchanged from its model portfolio for the three months ending in late September. However, the fund recorded a 1.7% quarterly loss during this period—the first loss in six quarters—due to a global slump in bond prices and the appreciation of the yen.

智通财经•2026/11/06 08:27

GlaxoSmithKline endorses: anti-inflammatory biotech company Rezera (RZRA.US) plans to raise $200 millions through IPO, with a valuation of $254 millions

Rezera plans to raise $200 million in its IPO on Nasdaq, with an offering price between $11 and $13. GSK intends to subscribe for up to $25 million. The mid-point valuation is $254 million, and the company focuses on oral NLRP3 inhibitors.

智通财经•2026/11/06 07:56